Atlas Trials

Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study

Clinical trial NCT03555617 · COMPLETED

Trial details

NCT number
NCT03555617
Sponsor
Theravance Biopharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Inflammatory Bowel Disease
Start date
2018-06-13
Primary completion
2018-07-15
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.